arrow
G

Guilherme Rabinowits

morsani college of medicine
H指数:28
被引数:6,292

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting
2022-09-013
OAAI
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53
2021-07-221
OAAI
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck
2019-09-0110
OAAI
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
2019-03-0118
OAAI
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma
2018-09-0121
PREAI
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Cemiplimab在晚期皮肤鳞状细胞癌中的PD-1阻滞

2018-07-26983
OAAI